The Center for Biotechnology & Interdisciplinary Studies at Rensselaer

The Center for Biotechnology & Interdisciplinary Studies (CBIS) is uniquely focused on fostering collaborative research across disciplines. Researchers from life sciences, physical science, informatics, bioengineering, data modeling, bioimaging, engineering, lighting systems and engineering, and media technologies can come together to work on global challenges.

As the hub of biotechnology-based research at Rensselaer Polytechnic Institute, the Center is recognized for its basic and applied research, world-class infrastructure and support staff, and growing funding base.

Our research portfolio includes ground-breaking work in biologics, bioimaging, biomanufacturing, biomolecular science and engineering, biophysics and structural biology, microbiomics, neuroscience, stem cell engineering, and genomics.  More about CBIS

Over Ten Years

  • 36 Faculty
  • 200 Ph.D.s Granted
  • 1,000 Undergrads Trained
  • 2,000 Peer-Reviewed Publications
  • 30,000 Citations (ISI)
  • $130MExternal Grant Funding

News & Events

Rensselaer-Designed Experiment Operating Aboard International Space Station

TROY, N.Y. — A novel experiment aimed at studying the mechanics of amyloid fibrils — a type of protein aggregation associated with diseases like diabetes, Alzheimer’s, and Parkinson’s — started today aboard the International Space Station (ISS), led by a team at Rensselaer Polytechnic Institute.

Cardiac Cell Symmetry Could Unlock Greater Understanding of Healthy Heart Formation

Like many other cells and organs within the body, cardiac cells possess a type of asymmetry that may play an important role in healthy heart formation and could serve as the basis for interventions to prevent congenital heart defects.

Rensselaer-Designed Platform Could Enable Personalized Immunotherapy

An innovative testing platform that more closely mimics what cancer encounters in the body may allow for more precise, personalized therapies by enabling the rapid study of multiple therapeutic combinations against tumor cells. The platform, which uses a three-dimensional environment to more closely mirror a tumor microenvironment, is demonstrated in research published in Communications Biology.

Rensselaer Team Aims To Pave Way for Robust AI in Medical Imaging

A number of vulnerabilities, known collectively as deep learning adversaries, hold artificial intelligence (AI) back from its full potential in applications like improving medical imaging quality and computer-aided diagnosis.

Our Center

  • 150 PhD Students
  • 50 Postdoctoral Fellows
  • 33 Principal Investigator Laboratories
  • 25 Visiting Research Scientists
  • 218,000 sq ft modern facility
  • 31, 240 sq ft of open research labs
  • 13,009 sq ft of support labs
  • 27,350 sq ft of core facilities
  • 5,830 sq ft conference and seminar space